Acorda Therapeutics Inc (ACORQ)
0.8479
+0.15
(+21.13%)
USD |
OTCM |
May 01, 15:51
Acorda Therapeutics Cash from Investing (TTM): -0.264M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -0.264M |
September 30, 2023 | -0.097M |
June 30, 2023 | -0.027M |
March 31, 2023 | -0.097M |
December 31, 2022 | -0.136M |
September 30, 2022 | -0.26M |
June 30, 2022 | -0.11M |
March 31, 2022 | -0.176M |
December 31, 2021 | 73.78M |
September 30, 2021 | 78.80M |
June 30, 2021 | 98.95M |
March 31, 2021 | 122.23M |
December 31, 2020 | 59.36M |
September 30, 2020 | 110.34M |
June 30, 2020 | 86.92M |
March 31, 2020 | 28.66M |
December 31, 2019 | -0.505M |
September 30, 2019 | -71.33M |
June 30, 2019 | -70.77M |
March 31, 2019 | -83.41M |
December 31, 2018 | -176.86M |
September 30, 2018 | -162.08M |
June 30, 2018 | -161.08M |
March 31, 2018 | -116.44M |
December 31, 2017 | -10.71M |
Date | Value |
---|---|
September 30, 2017 | -10.98M |
June 30, 2017 | -11.49M |
March 31, 2017 | -277.94M |
December 31, 2016 | -73.79M |
September 30, 2016 | -42.43M |
June 30, 2016 | -50.37M |
March 31, 2016 | 229.11M |
December 31, 2015 | -85.24M |
September 30, 2015 | -9.311M |
June 30, 2015 | -261.92M |
March 31, 2015 | -398.42M |
December 31, 2014 | -293.82M |
September 30, 2014 | -418.66M |
June 30, 2014 | -179.18M |
March 31, 2014 | -55.36M |
December 31, 2013 | -45.09M |
September 30, 2013 | -43.09M |
June 30, 2013 | -64.72M |
March 31, 2013 | -65.05M |
December 31, 2012 | -71.28M |
September 30, 2012 | -74.35M |
June 30, 2012 | -76.31M |
March 31, 2012 | -108.21M |
December 31, 2011 | -45.02M |
September 30, 2011 | -70.02M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-71.33M
Minimum
Sep 2019
122.23M
Maximum
Mar 2021
27.12M
Average
-0.097M
Median
Mar 2023
Cash from Investing (TTM) Benchmarks
BioSig Technologies Inc | -0.186M |
Verve Therapeutics Inc | 27.69M |
Spectral AI Inc | -- |
AIM ImmunoTech Inc | -0.832M |
Protalix BioTherapeutics Inc | -16.71M |